46 /100
MEDIUM RISK
Score updated Apr 13, 2026

KAPA

Kairos Pharma, Ltd. — Stock Dilution Tracker

Track KAPA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track KAPA — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
37
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
🔄 Reverse Split 55%
• 50-day avg $0.61 below $1 exchange minimum
🔁 Convertible Conversion 15%
• Convertible debt present: 5.1% potential dilution
🔔 Track KAPA — Get forecast alerts →
💹 Market Data
Market Cap$12.49M
Shares Outstanding21.41M
Float12.42M
Cash$4.49M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 88.8% shares (2025Q4 vs prior)
15 institutional holders · 879.5K shares
#1 CITADEL ADVISORS LLC 321.7K shares
#2 VANGUARD GROUP INC 131.8K shares
#3 TWO SIGMA INVESTMENTS, LP 94.0K shares
+ 12 more holders Sign up free to view →
📉 Short Interest
Short Interest236.2K
Days to Cover2.2
% of Float1.9%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account
📰 Recent News
Kairos Pharma signs deal for Celyn Therapeutics’ CL-273 Pharmaceutical Technology · Mar 03
Track KAPA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KAPA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required